En un rincón remoto del espacio, mucho antes de que existieran las estrellas, los planetas o incluso las galaxias, nacieron las primeras partículas que aún hoy siguen atravesando el universo. Algunas de ellas han viajado durante más de 13.800 millones de años, conv …
Litomercantes del Sur impulsa oportunidades laborales en el sector fintech en México El crecimiento del sector fintech en América Latina ha generado nuevas oportunidades laborales para miles de profesionales en la región. En este contexto, Litomercantes del Sur, firma d …
Litomercantes conecta talento latino con fintech global Read More »
Durante décadas, los chimpancés han ocupado el trono de la inteligencia animal en el imaginario colectivo. Su cercanía genética con los humanos —comparten alrededor del 98% de nuestro ADN— parecía una garantía incuestionable de superioridad cogni …
While Johnson & Johnson retains the top revenue rank across the major pharma companies, Eli Lilly last year established itself as the clear leader in the obesity market, in the process capturing investors’ attention and enthusiasm.
J&J Reigns as Top Pharma by Revenue While Lilly Leapfrogs on Strong Obesity Sales Read More »
The major pharmas are loaded up with trillions in firepower—but are sticking to mid-cap deals. One expert says it might be time to think outside the box and shake up the industry with some consolidation.
In Tight Deal Environment, Pharma May Need To Think Big Read More »
This webinar introduces the DIA Artificial Intelligence Consortium, a neutral, public‑private partnership that convenes regulators, biopharmaceutical companies, academia, and technology providers, including FDA, Health Canada, MHRA, PMDA, IQVIA, Gilead, Otsuka, BeOne Medicines, Beth Israel Deaconess Medical Center–Yale School of Medicine, and others.
Webinar: Operationalizing AI in Drug Development: Inside DIA’s Global AI Consortium Read More »
The medtech company believes the cyberattack has been contained and is now bringing systems back online.
Stryker begins restoring ordering, shipping systems after cyberattack Read More »
No siempre es un error evidente. A veces no hay una operación fallida ni un diagnóstico claramente equivocado. En muchos casos, el problema es más sutil: una prueba que llega tarde, una decisión que se retrasa o una señal clínica que pasa desaperci …
James Cleary will step down from the post on June 30, but stay on as an adviser to the company through the end of the year. He’s the second finance chief of a drug distributor to announce their retirement this month.
The Federal Trade Commission said the transaction had threatened to raise prices and stifle innovation for cataract laser eye surgery systems.
Alcon abandons effort to purchase LENSAR after FTC scrutiny Read More »
